News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
851,713 Results
Type
Article (87079)
Company Profile (663)
Press Release (763952)
Multimedia
Podcasts (163)
Webinars (22)
Section
Business (232699)
Career Advice (4133)
Deals (39779)
Drug Delivery (133)
Drug Development (91104)
Employer Resources (201)
FDA (18182)
Job Trends (17381)
News (396675)
Policy (39861)
Tag
Academia (2996)
Academic (1)
Accelerated approval (17)
Adcomms (31)
Allergies (109)
Alliances (56866)
ALS (125)
Alzheimer's disease (1610)
Antibody-drug conjugate (ADC) (194)
Approvals (18175)
Artificial intelligence (371)
Autoimmune disease (46)
Automation (18)
Bankruptcy (405)
Best Places to Work (12558)
BIOSECURE Act (22)
Biosimilars (146)
Biotechnology (449)
Bladder cancer (108)
Brain cancer (40)
Breast cancer (388)
Cancer (3205)
Cardiovascular disease (239)
Career advice (3547)
Career pathing (36)
CAR-T (219)
CDC (39)
Cell therapy (584)
Cervical cancer (25)
Clinical research (74508)
Collaboration (1175)
Company closure (4)
Compensation (725)
Complete response letters (47)
COVID-19 (2910)
CRISPR (72)
C-suite (436)
Cystic fibrosis (123)
Data (3366)
Decentralized trials (2)
Denatured (58)
Depression (82)
Diabetes (324)
Diagnostics (6914)
Digital health (20)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (182)
Drug pricing (161)
Drug shortages (30)
Duchenne muscular dystrophy (172)
Earnings (97493)
Editorial (52)
Employer branding (25)
Employer resources (169)
Events (130989)
Executive appointments (816)
FDA (20026)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (973)
Gene editing (149)
Generative AI (33)
Gene therapy (452)
GLP-1 (913)
Government (5311)
Grass and pollen (5)
Guidances (284)
Healthcare (20810)
HIV (38)
Huntington's disease (33)
IgA nephropathy (50)
Immunology and inflammation (209)
Immuno-oncology (17)
Indications (40)
Infectious disease (3106)
Inflammatory bowel disease (175)
Inflation Reduction Act (13)
Influenza (77)
Intellectual property (137)
Interviews (814)
IPO (17828)
IRA (59)
Job creations (5195)
Job search strategy (2863)
Kidney cancer (14)
Labor market (69)
Layoffs (614)
Leadership (28)
Legal (10115)
Liver cancer (83)
Longevity (10)
Lung cancer (471)
Lymphoma (237)
Machine learning (20)
Management (65)
Manufacturing (511)
MASH (110)
Medical device (14480)
Medtech (14494)
Mergers & acquisitions (22567)
Metabolic disorders (917)
Multiple sclerosis (109)
NASH (22)
Neurodegenerative disease (168)
Neuropsychiatric disorders (43)
Neuroscience (2421)
NextGen: Class of 2025 (7672)
Non-profit (5073)
Now hiring (53)
Obesity (473)
Opinion (298)
Ovarian cancer (109)
Pain (126)
Pancreatic cancer (120)
Parkinson's disease (192)
Partnered (24)
Patents (325)
Patient recruitment (223)
Peanut (54)
People (65697)
Pharmaceutical (131)
Pharmacy benefit managers (24)
Phase I (22996)
Phase II (32391)
Phase III (24356)
Pipeline (2206)
Policy (266)
Postmarket research (3552)
Preclinical (10374)
Press Release (72)
Prostate cancer (154)
Psychedelics (45)
Radiopharmaceuticals (270)
Rare diseases (552)
Real estate (7403)
Recruiting (76)
Regulatory (27365)
Reports (62)
Research institute (2662)
Resumes & cover letters (650)
Rett syndrome (7)
RNA editing (15)
RSV (59)
Schizophrenia (114)
Series A (168)
Series B (126)
Service/supplier (27)
Sickle cell disease (68)
Special edition (24)
Spinal muscular atrophy (166)
Sponsored (38)
Startups (4308)
State (2)
Stomach cancer (14)
Supply chain (78)
Tariffs (81)
The Weekly (103)
Vaccines (948)
Venture capital (62)
Weight loss (332)
Women's health (51)
Worklife (21)
Date
Last 7 days (460)
Last 30 days (2025)
Last 365 days (28718)
2025 (19876)
2024 (35515)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1272)
Alabama (76)
Alaska (7)
Arizona (273)
Arkansas (9)
Asia (50650)
Australia (8906)
California (7812)
Canada (2301)
China (791)
Colorado (265)
Connecticut (318)
Delaware (210)
Europe (115918)
Florida (1024)
Georgia (231)
Hawaii (3)
Idaho (64)
Illinois (610)
India (44)
Indiana (380)
Iowa (17)
Japan (248)
Kansas (121)
Kentucky (26)
Louisiana (17)
Maine (58)
Maryland (1088)
Massachusetts (5940)
Michigan (255)
Minnesota (409)
Mississippi (4)
Missouri (77)
Montana (26)
Nebraska (26)
Nevada (88)
New Hampshire (57)
New Jersey (2209)
New Mexico (29)
New York (2158)
North Carolina (1242)
North Dakota (9)
Northern California (3551)
Ohio (220)
Oklahoma (15)
Oregon (46)
Pennsylvania (1605)
Puerto Rico (17)
Rhode Island (32)
South America (1650)
South Carolina (15)
South Dakota (1)
Southern California (2938)
Tennessee (67)
Texas (1131)
United States (28489)
Utah (191)
Virginia (199)
Washington D.C. (67)
Washington State (700)
West Virginia (3)
Wisconsin (63)
851,713 Results for "bi biotech india pvt ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Sponsored
Taipei City Government Partners With Six Biotech Companies to Showcase at BIO International Convention 2025
The 2025 BIO International Convention (BIO2025), the world’s largest annual biotech event, will take place from June 16 to 19 (U.S. time) at the Boston Convention & Exhibition Center. This year, Taipei City Government is partnering with six Taipei-based biotech companies, including PanCAD.ai Co., Ltd., Instant NanoBiosensors Co., Ltd., Bened Biomedical Co., Ltd., Cancer Free Biotech Ltd., Xantho Biotechnology Co., Ltd., and Energenesis Biomedical Co., Ltd., to showcase their innovations at the Taiwan Pavilion (Booth #1645) in the Taipei Exhibition Area.
June 16, 2025
·
5 min read
IPO
SPACs Line Up To Clear Biotech’s IPO Backlog
Blank check deals dwindled after a crazy 2021. Now, biotechs are starting to turn to special purpose acquisition companies again as an easy route to the public markets.
September 3, 2025
·
6 min read
·
Annalee Armstrong
Press Releases
NKGen Biotech, Inc. Announces Completion of NKMax Co., Ltd. Acquisition; Gains Full Control of Global Manufacturing and Intellectual Property Assets
September 10, 2025
·
8 min read
Mergers & Acquisitions
Hectic Markets, Emotions Lead Biotechs To Tack On CVRs
Contingent value rights are rising in a down market, helping to close the gap between buyer and seller expectations in biotech transactions.
September 10, 2025
·
6 min read
·
Annalee Armstrong
Press Releases
Medicus Pharma Ltd. to Present at BTIG Virtual Biotech Conference 2025
Executive Chairman & CEO of the Company to Participate in a Fireside Chat
July 21, 2025
·
6 min read
Mergers & acquisitions
Tang Capital’s Concentra on Buyout Binge With Plenty of Biotech Fodder
After a slow 2024, the biotech shell company Concentra Biosciences is back, offering to buy four biotechs in the past month and seven so far this year.
August 13, 2025
·
4 min read
·
Annalee Armstrong
Press Releases
Jyong Biotech Ltd. Participated in the 22nd Urological Association of Asia Congress to Display the Clinical Data for its Phase III Studies of BOTRESO and Phase II Study of MCS-8 (PCP)
August 22, 2025
·
6 min read
Press Releases
Jyong Biotech Ltd. Announces Closing of $20 Million Initial Public Offering
June 18, 2025
·
5 min read
Press Releases
Jyong Biotech Ltd. Announces Pricing of $20 Million Initial Public Offering
June 17, 2025
·
5 min read
Earnings
Q2 2025: Biotechs To Watch For This Earnings Season
Second-quarter earnings come amid many high-level challenges for the biopharma industry. How will these five closely watched biotechs fare?
July 24, 2025
·
10 min read
·
Tristan Manalac
1 of 85,172
Next
